Results 31 to 40 of about 395,319 (225)

Comparison of same day diagnostic tools including Gene Xpert and unstimulated IFN-γ for the evaluation of pleural tuberculosis: a prospective cohort study [PDF]

open access: yes, 2014
Background: The accuracy of currently available same-day diagnostic tools (smear microscopy and conventional nucleic acid amplification tests) for pleural tuberculosis (TB) is sub-optimal. Newer technologies may offer improved detection.
Jonny Peter   +23 more
core   +2 more sources

Different Therapeutic Strategies in 2 Young Patients with Advanced ALK-Rearranged Lung Adenocarcinoma: “The Light at the End of the Tunnel”

open access: yesCase Reports in Oncology, 2021
Malignant pleural effusion represents a prognostic negative factor on survival conferring stage IV disease. The median of survival is 5 months and a 5-year survival of about 3%.
Umberto Caterino   +8 more
doaj   +1 more source

Pleural Effusions in Hematologic Malignancies

open access: yesChest, 2004
Nearly all hematologic malignancies can occasionally present with or develop pleural effusions during the clinical course of disease. Among the most common disorders are Hodgkin and non-Hodgkin lymphomas, with a frequency of 20 to 30%, especially if mediastinal involvement is present.
Alexandrakis, MG   +3 more
openaire   +3 more sources

Diagnostic Values of Vascular Endothelial Growth Factor and Epidermal Growth Factor Receptor for Benign and Malignant Hydrothorax

open access: yesChinese Medical Journal, 2015
Background: Hydrothorax, as one of the common complications of malignant tumors, still cannot be sensitively detected in clinical practice, thus requiring a sensitive, specific method for diagnosis.
Yan Gu   +10 more
doaj   +1 more source

Multiplexed serpentine microchannels for high-throughput sorting of disseminated tumor cells from malignant pleural effusion

open access: yes, 2021
Accurate isolation and detection of disseminated tumor cells from the malignant pleural effusion (MPE) is of significant clinical importance. Cytology is a routine diagnostic tool for the analysis of MPE.
Zhu, Zhixian   +15 more
core   +1 more source

Reactive oxygen species modulator 1, a novel protein, combined with carcinoembryonic antigen in differentiating malignant from benign pleural effusion

open access: yesTumor Biology, 2017
The differential diagnosis of malignant pleural effusion and benign pleural effusion remains a clinical problem. Reactive oxygen species modulator 1 is a novel protein overexpressed in various human tumors. The objective of this study was to evaluate the
Xianmeng Chen   +3 more
doaj   +1 more source

The Diagnostic Value of carcinoembryonic Antigen and cancer Antigen 125 in Malignant Pleural Effusion [PDF]

open access: yesZagazig University Medical Journal
Many studies have proved that carcinoembryonic antigen (CEA) and cancer antigen 125 (CA125) have high affinity and binding specificity, and can be used to distinguish pleural effusion in patients with malignant and non-malignant pleural effusion.
Adel Elghamrawy   +3 more
doaj   +1 more source

Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. [PDF]

open access: yes, 2011
BACKGROUND: The effects of extra-pleural pneumonectomy (EPP) on survival and quality of life in patients with malignant pleural mesothelioma have, to our knowledge, not been assessed in a randomised trial.
Kilburn, L.S.   +59 more
core   +1 more source

Intrapatient tumour heterogeneity and clonal evolution in an autopsy study of metastatic salivary gland cancer

open access: yesMolecular Oncology, EarlyView.
Tumour heterogeneity and clonal evolution of metastatic salivary gland cancer were evaluated in two patients with adenoid carcinoma and one patient with myoepithelial carcinoma. Radiology‐guided autopsy enabled multi‐region sampling (total samples n = 149), followed by whole‐genome sequencing and phylogenetic reconstruction (17 tumour samples, 4–7 per ...
Gerben Lassche   +10 more
wiley   +1 more source

Utility of Emerging Novel Criteria “Cancer Ratio” and “Cancer Ratio Plus” in Differentiating Malignant from Nonmalignant Pleural Effusions [PDF]

open access: yesIndian Journal of Respiratory Care
Background and objectives: Distinguishing between malignant and benign pleural effusion (including tuberculous pleuritis with effusion) is vital for any patient with an exudative pleural effusion.
Humaira Javaid   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy